Combined therapy for secondary prophylaxis of variceal rebleeding?
University of Miami, School of Medicine/Mt. Sinai Medical Center, Florida, USA.
Diego
D
Maldonado
Jamie S
JS
Barkin
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004724:Endoscopy; D004932:Esophageal and Gastric Varices / Q000188:drug therapy* / Q000601:surgery*; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000517:prevention & control / Q000601:surgery*; D006439:Hemodynamics; D006801:Humans; D007548:Isosorbide Dinitrate / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use*; D008026:Ligation; D009248:Nadolol / Q000008:administration & dosage / Q000627:therapeutic use*; D011183:Postoperative Complications; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D016019:Survival Analysis; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D014665:Vasodilator Agents; D009248:Nadolol; D007548:Isosorbide Dinitrate; C030397:isosorbide-5-mononitrate